Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistant Staphylococcus aureus. (Q54133149)

25 May 2018

title

Intracellular activity of vancomycin and Ly333328, a new semisynthetic glycopeptide, against methicillin-resistant Staphylococcus aureus. (English)

1 reference

25 May 2018

methicillin-resistant Staphylococcus aureus

main subject

0 references

vancomycin

1 reference

inferred from title

Staphylococcus aureus

1 reference

B al-Nawas

1

1 reference

25 May 2018

P M Shah

series ordinal

2

1 reference

25 May 2018

publication date

1 May 1998

1 reference

25 May 2018

published in

Infection

1 reference

25 May 2018

volume

26

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

165-167

1 reference

25 May 2018

https://scigraph.springernature.com/pub.10.1007/bf02771843

exact match

0 references

cites work

Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02771843

Antibiotic penetration of and bactericidal activity within endothelial cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02771843

Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin.

21 January 2018

1 reference

12 December 2020

Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium

1 reference

12 December 2020

In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

12 December 2020

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci

1 reference

12 December 2020

Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02771843

1 reference

25 May 2018

1 reference

25 May 2018